Reference Standards & Materials
DocumentsDRE-C10962000

QEMIX supplies the CoA matching the lot actually shipped, together with the official technical documentation issued by the manufacturer.

Reference Standards & Materials · Pharmaceutical Reference Standards · Active Pharmaceutical Ingredients (APIs) SKU: DRE-C10962000

Captopril

Brand: DR. EHRENSTORFER
Reviews: (0)
Also known as: L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)-; 1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline; (-)-1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline; (-)-Captopril; Acediur; Aceplus; Acepress; Acepril; Aceten; Aceten 25; Alopresin; Angiopril; Capoten; Capotril; CaptoHexal; Captolane; Captomax; Capton; Captopril; Captopril GP; Captopril Generis; Captopril Mepha; Captopril ratiopharm; Captoril; Captotec; Cesplon; Dilabar; Facopril; Farcopril; Garranil; Hipertil; Hypopress; L-Captopril; Lopirin; Lopril; Lotensine; Novocaptopril; S-Captopril; SA 333; SQ 14225; Tensiomin; Tensobon; Tensoprel; Zapto
Brand: DR. EHRENSTORFER  ·  Origin: Germany
Pack sizes & price list
SKU Pack size Availability Price
DRE-C10962000 250 mg Backorder Request a quote
Legal compliance: Quotations and the supply of products are carried out in compliance with the laws of Vietnam.
About this product

Captopril – formula C9H15NO3S, CAS 62571-86-2, molecular weight 217.29 g/mol – is an analytical reference standard (CRM/RM) in the Active Pharmaceutical Ingredients (APIs) group from DR. EHRENSTORFER (Germany). Specification: pack size 250 mg. It is commonly used for instrument calibration, calibration curves and QA/QC in HPLC, GC, GC-MS, LC-MS and ICP/AAS analysis. QEMIX supplies genuine Captopril with full COA/SDS, Quick Quote and nationwide delivery in Vietnam. Contact us for partner pricing and technical support.

Product details
CAS No
62571-86-2
Chemical formula
C9H15NO3S
Origin
Germany
Brand
DR. EHRENSTORFER
Pack size
250 mg
SKU
DRE-C10962000
You may also like

Recommended products

View all
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Captopril”